An important hallmark of these highly glycolytic tumor cells is the high need for the recovery of NAD+ from NADH [43,44], which is managed by the conversion of the glycolytic end-product pyruvate towards lactate by the action of lactate dehydrogenase A (LDHA). Here, LDHA is linked to neoplasm.